Loading stock data…
Illumina, Inc. (ILMN)
$211.06-7.16 (-3.28%)
Market ClosedLast close Sep 8
Illumina, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Illumina, Inc. in the Healthcare sector is trading at $211.06 with a market capitalization of $31.9B. Wall Street consensus targets $199.63 (19 analysts), implying a -5.4% move over the next 12 months. The stock is currently near its 52-week high of $231.81, remaining 38.6% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -5.4% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $1.09B↓ | $1.16B↑ | $1.08B↑ | $1.06B |
| Gross Profit | — | $721.00M↓ | $759.00M↑ | $733.00M↑ | $695.00M |
| Operating Income | — | $209.00M↓ | $211.00M↓ | $227.00M↑ | $214.00M |
| Net Income | — | $134.00M↓ | $334.00M↑ | $150.00M↓ | $235.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consu...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$31.87B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
39.30
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
1.77M
Recent News
3 Stocks Soon Joining the S&P 500
The S&P 500 is set for another shakeup, with Bloom Energy (BE), Everpure (P), and Illumina (ILMN) all joining in the next quarterly rebalancing near the end of September.
ILMN Stock Keeps Climbing. Should You Climb On?
A gene sequencing leader is on a powerful run fueled by real business quality, forcing investors to decide if the engine has more power than the price tag already reflects.
3 Promising Genomics Stocks in the Spotlight in 2026
Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.
Bloom Energy Stock Rallies on News of S&P 500 Addition
Shares of Bloom Energy are surging on the news that the company is set to join the S&P 500.
Bloom Energy’s S&P 500 Entry Could Bring A New Wave Of Buyers, Says Clear Street — Projects 20% Upside In BE Stock
Bloom Energy is set to join the S&P 500 before trading begins on September 21.